- Home
- DNTH vs STBA Comparison
DNTH vs STBA Comparison
Compare DNTH & STBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DNTH | STBA |
|---|---|---|
| Founded | 2015 | 1902 |
| Country | United States | United States |
| Employees | N/A | 1206 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.6B |
| IPO Year | 2018 | 1995 |
Fundamental Metrics
Financial Performance| Metric | DNTH | STBA |
|---|---|---|
| Price | $53.87 | $44.09 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 6 |
| Target Price | ★ $71.22 | $43.00 |
| AVG Volume (30 Days) | ★ 698.2K | 227.4K |
| Earning Date | 04-06-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.27% |
| EPS Growth | ★ 69.82 | N/A |
| EPS | N/A | ★ 2.60 |
| Revenue | ★ $6,235,000.00 | N/A |
| Revenue This Year | N/A | $10.09 |
| Revenue Next Year | N/A | $4.21 |
| P/E Ratio | ★ N/A | $16.95 |
| Revenue Growth | ★ 120.63 | N/A |
| 52 Week Low | $13.37 | $30.84 |
| 52 Week High | $57.50 | $44.87 |
Technical Indicators
Market Signals| Indicator | DNTH | STBA |
|---|---|---|
| Relative Strength Index (RSI) | 60.72 | 58.62 |
| Support Level | $33.94 | $36.18 |
| Resistance Level | $57.50 | $44.80 |
| Average True Range (ATR) | 3.08 | 1.13 |
| MACD | 0.12 | -0.12 |
| Stochastic Oscillator | 92.21 | 73.85 |
Price Performance
Historical ComparisonAbout DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About STBA S&T Bancorp Inc.
S&T Bancorp Inc is a bank holding company. The company operates in five markets including Western Pennsylvania, Eastern Pennsylvania, Northeast Ohio, Central Ohio and Upstate New York. The company provides financial services with retail and commercial banking products, cash management services, trust and brokerage services. It operates only in one segment which is Community Banking. The company earns revenue from interest on loans and securities and fees charged for financial services provided to its customers.